ARTICLE | Company News
Azee Inc., Oscient deal
July 11, 2005 7:00 AM UTC
Azee received a license from OSCI to an undisclosed IP that relates to Azee's small molecule anti-genomic therapeutics (SMATs), which bind DNA. OSCI received an equity stake in Azee and is eligible fo...